LCC 2 – Play Your Part is launched

BOPA is delighted to announce the launch of the Let’s Communicate Cancer Series Part 2 – Play Your Part.

 

These are learning and campaign materials to help you to play your part in prevention, early diagnosis and treatment of cancer. It features, short red flag animations on breast, lung, genitourinary and blood cancers, three series of factsheets, and a schedule of Healthy Living Campaigns with access to free materials.

They designed for all members of the pharmacy team. You can use it to prepare for conversations with customers in the pharmacy and you can use it to quickly access information when speaking to patients on cancer treatment.

The CancerHUB has been designed by the Let’s Communicate Cancer team to compliment the e-learning package and encourage you to Play Your Part in early cancer diagnosis and treatment.

You will need to be logged in as a free associate to view these videos. To join click here: https://www.bopa.org.uk/join-bopa/

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article